Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01023074 · ClinicalTrials.gov registry record · NA
Effects of Training on Central Auditory Function in Multiple Sclerosis
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT01023074: Completed NA study, sponsored by VA Office of Research and Development.
NCT01023074 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01023074, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the central auditory processing (CAP) deficits that result from multiple sclerosis (MS).
Interventions
- BEHAVIORAL Auditory training
- OTHER MS: Control Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01023074
The ClinicalTrials.gov registry entry for NCT01023074 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Auditory training is the first listed.
NCT01023074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01023074 about?
NCT01023074 is a clinical study titled "Effects of Training on Central Auditory Function in Multiple Sclerosis". The purpose of this study is to characterize the central auditory processing (CAP) deficits that result from multiple sclerosis (MS).
What is the current status of trial NCT01023074?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2007-10. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01023074?
The interventions under investigation include: Auditory training (BEHAVIORAL), MS: Control Activity (OTHER).
Who is sponsoring clinical trial NCT01023074?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.